These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31255638)

  • 21. French validation of the Foot Function Index (FFI).
    Pourtier-Piotte C; Pereira B; Soubrier M; Thomas E; Gerbaud L; Coudeyre E
    Ann Phys Rehabil Med; 2015 Oct; 58(5):276-82. PubMed ID: 26343763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score.
    Jerath NU; Shy ME
    J Clin Neurophysiol; 2017 Nov; 34(6):508-511. PubMed ID: 28914656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between physical performance and quality of life in Charcot-Marie-Tooth disease: a pilot study.
    Roberts-Clarke D; Fornusek C; Saigal N; Halaki M; Burns J; Nicholson G; Fiatarone Singh M; Hackett D
    J Peripher Nerv Syst; 2016 Dec; 21(4):357-364. PubMed ID: 27699915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
    Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
    Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients.
    Don R; Serrao M; Vinci P; Ranavolo A; Cacchio A; Ioppolo F; Paoloni M; Procaccianti R; Frascarelli F; De Santis F; Pierelli F; Frascarelli M; Santilli V
    Clin Biomech (Bristol, Avon); 2007 Oct; 22(8):905-16. PubMed ID: 17686557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hand involvement in children with Charcot-Marie-Tooth disease type 1A.
    Burns J; Bray P; Cross LA; North KN; Ryan MM; Ouvrier RA
    Neuromuscul Disord; 2008 Dec; 18(12):970-3. PubMed ID: 18993073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressure characteristics in painful pes cavus feet resulting from Charcot-Marie-Tooth disease.
    Crosbie J; Burns J; Ouvrier RA
    Gait Posture; 2008 Nov; 28(4):545-51. PubMed ID: 18456499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balance impairment in pediatric charcot-marie-tooth disease.
    Estilow T; Glanzman AM; Burns J; Harrington A; Cornett K; Menezes MP; Shy R; Moroni I; Pagliano E; Pareyson D; Bhandari T; Muntoni F; Laurá M; Reilly MM; Finkel RS; Eichinger KJ; Herrmann DN; Troutman G; Bray P; Halaki M; Shy ME; Yum SW;
    Muscle Nerve; 2019 Sep; 60(3):242-249. PubMed ID: 31026080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised controlled trial protocol of foot and ankle exercise for children with Charcot-Marie-Tooth disease.
    Sman AD; Raymond J; Refshauge KM; Menezes MP; Walker T; Ouvrier RA; Burns J
    J Physiother; 2014 Mar; 60(1):55; discussion 55. PubMed ID: 24856942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-cultural adaptation and validation of the Foot Function Index for use in German-speaking patients with foot complaints.
    Naal FD; Impellizzeri FM; Huber M; Rippstein PF
    Foot Ankle Int; 2008 Dec; 29(12):1222-8. PubMed ID: 19138487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study.
    Pazzaglia C; Camerota F; Germanotta M; Di Sipio E; Celletti C; Padua L
    J Neurol; 2016 Jul; 263(7):1434-41. PubMed ID: 27177999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathic pain in patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Peric S; Basta I; Bozovic I; Kacar A; Marjanovic A; Ivanovic V; Brankovic M; Jankovic M; Novakovic I; Rakocevic Stojanovic V
    Neurol Sci; 2020 Mar; 41(3):625-630. PubMed ID: 31729581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Established and novel measures of upper limb impairment in children with Charcot-Marie-tooth disease type 1A and riboflavin transporter deficiency type 2.
    Cornett KMD; Menezes MP; Bray P; Halaki M; Burns J
    J Peripher Nerv Syst; 2018 Mar; 23(1):29-35. PubMed ID: 29168276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The characteristics of gait in Charcot-Marie-Tooth disease types I and II.
    Newman CJ; Walsh M; O'Sullivan R; Jenkinson A; Bennett D; Lynch B; O'Brien T
    Gait Posture; 2007 Jun; 26(1):120-7. PubMed ID: 17010610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
    Shy ME; Chen L; Swan ER; Taube R; Krajewski KM; Herrmann D; Lewis RA; McDermott MP
    Neurology; 2008 Jan; 70(5):378-83. PubMed ID: 18227419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability and validity of the Manual Ability Measure-36 in persons with Charcot-Marie-Tooth disease.
    Poole JL; Huffman M; Hunter A; Mares C; Siegel P
    J Hand Ther; 2015; 28(4):364-7; quiz 368. PubMed ID: 26318522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.